Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Split-face comparison of subcision with PDRN versus subcision with non-cross-linked hyaluronic acid for rolling acne scars

Official title: Subcision With Injection of Poly Deoxyribonucleotide Versus Subcision With Injection of Non-cross Linked Hyaluronic Acid in Rolling Acne Scars Treatment : A Split Face Randomized Controlled Clinical Trial.

Run by Cairo University · NCT07547956 · Data updated 2026-11-12

This compares whether adding injections of PDRN or non-cross-linked hyaluronic acid to subcision works better to improve rolling acne scars in adults with bilateral moderate-to-severe scars.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedOctober 20, 2025
Main results expectedJune 20, 2026
Study endsJuly 20, 2026
Registry record updatedMay 18, 2026
Trial IDNCT07547956 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with bilateral moderate-to-severe rolling acne scars, stable acne for at least six months, and no scar procedures in the past year are ideal candidates.

Probably not a fit

People with active inflammatory acne, recent systemic retinoid use, pregnancy or breastfeeding, tendency to keloid, active infections (including HBV/HCV/HIV or herpes), lidocaine sensitivity, unapproved anticoagulant/antiplatelet use, or fish/salmon allergy are likely to be excluded and may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with bilateral moderate-to-severe rolling (atrophic) acne scars receive subcision on both sides of the face; one side is injected with polydeoxyribonucleotide (PDRN) and the other with non-cross-linked hyaluronic acid (HA). Clinical photographs and validated scar scales are used to measure changes in scar appearance and to record safety outcomes during follow-up visits. Eligible participants have stable acne, no scar treatments in the prior 12 months, and are aged 18 or older. The trial directly compares efficacy and adverse events between the two injectable agents when combined with subcision.

Why it matters

Potential benefit: If successful, this could identify which injectable gives better scar improvement when combined with subcision, helping patients choose a more effective treatment.

How similar studies have gone: Subcision combined with hyaluronic acid or other fillers is an established approach for rolling scars, while PDRN injections are less studied but have shown promising regenerative effects in small reports.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Moderate to severe mainly rolling acne scars per validated scale (Goodman \& Baron Grade 3-4)
2. Scars must be bilaterally distributed, allowing for split-face comparison
3. Stable acne (no active nodulocystic lesions, pustules, or recent outbreaks for ≥6 months)
4. No scar treatments (e.g., fillers, laser, microneedling) within the past 12 months
5. All skin types.
6. Both genders above 18 years old

Exclusion Criteria:

1. Systemic retinoid treatment within the last 6 months
2. Active inflammatory acne
3. Lidocaine sensitivity
4. Pregnancy and lactation
5. Severe systemic illness or malignancy
6. Use of anticoagulant or antiplatelet medications (unless cleared) Use of oral isotretinoin within the past 6 month
7. Herpes libialis, bacterial infection, other infections such as HBV, HCV or HIV
8. Tendency to keloid formation
9. Allergy to fish and salmon

Where it's running

  • Cairo University, Dermatology Department
    Cairo, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.